BME
BlackRock Health Sciences Trust
43.30$
-0.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
BlackRock Health Sciences Trust (BME) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 31 million $. Tick rows to compare them in a chart.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q2 17 | Q3 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q4 24 | Q2 25 | Q4 25 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.8 | 0.8 | 0.9 | 0.9 | 0.9 | 0.9 | 1.8 | 0.9 | 1.2 | 1.2 | 1.1 | 1.1 | 1.1 | 1.3 | 11 | 1.2 | 17 | 1.4 | 3.8 | 1.2 | 23 | 1.6 | 17 | 1.6 | 37 | 1.9 | 21 | 21 | 2.0 | 0.5 | 2.1 | 17 | 2.0 | 18 | 2.0 | -0.4 | 37 | 4.0 | 23 | 31 | |
| – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | 0.0 | 2.0 | – | 2.2 | – | 2.3 | – | 2.6 | – | 2.9 | – | 3.2 | – | 2.9 | 2.9 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | – | 3.1 | 3.3 | 2.8 | 2.9 | 2.8 | |
| 0.8 | 0.8 | 0.9 | 0.9 | 0.9 | 0.9 | -1.8 | 0.9 | 1.2 | 1.2 | 1.1 | 1.1 | 1.1 | 1.3 | 8.7 | 1.2 | 15 | 1.4 | 1.5 | 1.2 | 20 | 1.6 | 14 | 1.6 | 33 | 1.9 | 18 | 18 | 2.0 | -2.5 | 2.1 | 14 | 2.0 | 15 | 2.0 | -3.5 | 33 | 4.0 | 20 | 28 | |
| – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | 0.0 | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.9 | 1.8 | 0.9 | 0.9 | 0.9 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.1 | 1.1 | 1.2 | 1.2 | 1.4 | 1.4 | 1.5 | 1.5 | 1.6 | 1.6 | 1.5 | 1.5 | 1.5 | 1.6 | 1.6 | 1.5 | 2.3 | 1.6 | 6.6 | 1.6 | 3.2 | 56 | 3.0 | 2.5 | 2.8 | |
| 4.2 | 4.2 | 22 | 22 | 0.8 | 6.5 | -1.8 | 6.5 | 8.3 | 8.3 | 1.0 | 0.7 | 0.7 | 16 | -27 | 21 | 21 | 3.9 | 3.9 | 33 | 33 | 18 | 18 | 8.0 | 8.0 | 33 | 80 | 33 | 16 | 16 | 3.5 | 2.3 | 2.4 | 6.6 | 1.6 | -49 | 56 | 3.0 | -61 | 4.5 | |
| 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.3 | 36 | 0.1 | 44 | 0.2 | 11 | -0.2 | 69 | 0.1 | 40 | -0.1 | 19 | 0.4 | -62 | -62 | 0.4 | 36 | 0.6 | 11 | 0.4 | 8.7 | 0.4 | 46 | -22 | 1.0 | 81 | 23 | |
| – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | 0.0 | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | 0.0 | – | – | – | 0.0 | 0.0 | 0.0 | |
| -3.4 | -3.4 | 23 | 23 | 23 | 7.4 | -15 | 7.4 | 9.5 | 9.5 | 1.8 | 1.8 | 1.8 | 18 | 36 | 22 | 0.0 | 5.3 | 0.0 | 34 | 0.0 | 20 | 0.0 | 9.6 | 0.0 | -31 | -62 | 0.0 | 18 | 36 | 5.7 | 11 | 4.4 | 8.7 | 23 | 46 | -22 | -3.6 | 81 | 23 | |
| -3.4 | -3.4 | 23 | 23 | 0.0 | 7.4 | 0.0 | 7.4 | 9.2 | 9.2 | 0.0 | 1.7 | 1.7 | 18 | -18 | 22 | 0.0 | 5.1 | 0.0 | 35 | 0.0 | 20 | 0.0 | 0.0 | 0.0 | -32 | 0.4 | 0.0 | 18 | 0.0 | 5.1 | 0.0 | 3.9 | 0.0 | – | 46 | – | – | – | – | |
| -3.4 | -3.4 | 23 | 23 | 23 | 7.4 | -15 | 7.4 | 9.5 | 9.5 | 1.8 | 1.8 | 1.8 | 18 | 36 | 22 | 11 | 5.3 | 11 | 34 | 12 | 20 | 12 | 9.6 | 13 | -31 | -62 | 13 | 18 | 36 | 5.7 | 11 | 4.4 | 8.7 | 23 | 46 | -22 | -3.6 | 81 | 23 | |
| -3.4 | -3.4 | 23 | 23 | – | 7.4 | – | 7.4 | 9.2 | 9.2 | – | 1.7 | 1.7 | 18 | 18 | 22 | 22 | 5.1 | 5.1 | 35 | 35 | 20 | 20 | 9.6 | 9.6 | -32 | -62 | -32 | 18 | 36 | 5.1 | 11 | 3.9 | 8.7 | – | 46 | -22 | 1.0 | 81 | 23 |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.